Filing Details

Accession Number:
0001305773-18-000028
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-30 21:25:21
Reporting Period:
2018-04-26
Accepted Time:
2018-04-30 21:25:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1305773 Conformis Inc CFMS Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403401 Bradley Langdale C/O Conformis, Inc.
600 Technology Park Drive
Billerica MA 01821
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-04-26 75,764 $1.40 102,297 No 4 M Direct
Common Stock Disposition 2018-04-26 75,764 $1.52 26,533 No 4 S Direct
Common Stock Acquisiton 2018-04-27 4,236 $1.40 30,769 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-04-26 75,764 $0.00 75,764 $1.40
Common Stock Stock Option (right to buy) Disposition 2018-04-27 4,236 $0.00 4,236 $1.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,236 2018-05-28 No 4 M Direct
0 2018-05-28 No 4 M Direct
Footnotes
  1. This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
  2. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.47-$1.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. This option is fully vested.